Salute e Benessere

mAIbe and LenioBio announce a new strategic collaboration aimed at accelerating…

LenioBio's ultrafast, scalable expression system enables rapid production of complex antibodies, providing high-quality experimental data that feeds directly into mAIbe's AI models. LenioBio's ultrafast, scalable expression system enables rapid production of complex antibodies, providing high-quality experimental data that feeds directly into mAIbe's AI models. Through this integrated approach, the two teams will jointly: Together, mAIbe and LenioBio set a new standard for speed,...
PR Newswire
26/11/2025

InnotiveDx Wins £1 million Grant From PACE

InnotiveDx has demonstrated that its underlying UTI diagnostic technology can provide extremely accurate Bacterial ID and antimicrobial susceptibility test (AST) results in less than 60 minutes, with its benchtop assay accuracy exceeding 96% in blinded evaluations. InnotiveDx has transitioned this technology into fully working, automated prototypes. The £1m PACE grant will allow InnotiveDx to fully assess the accuracy and reliability of these prototype systems with thousands of clinical…
PR Newswire
26/11/2025

Sectra launches its built-in reporting solution in the US--accelerates…

Sectra Reporting is a native, built-in solution that streamlines diagnostic workflows by integrating directly with imaging data and measurements. To free up time for the radiologist to focus on diagnostics rather than on documentation, the solution has AI capabilities such as automated impression generation and external AI results seamlessly integrated. At the same time, deep links to measurements, annotations, and lesion-tracking data allow radiologists to embed precise, actionable references…
PR Newswire
26/11/2025

Flagship Foldable Phone to Highlight Huawei's Product Launch in Dubai

Huawei launched its first foldable phone, HUAWEI Mate X in 2019, and in the seven years since has led the way in foldable technology, driving innovations in design, reliability, and user experience. The company held a 70% market share in China's foldable phone market in the first half of 2025, according to an International Data Corporation (IDC) report, ranking first with over ten million devices shipped. HUAWEI Mate X7 features trailblazing dual-fold technology, enhanced reliability, along with…
PR Newswire
26/11/2025

Curasight's uTREAT® Phase 1 Trial in Brain Cancer Now Open for Patient…

The phase 1 trial is part of Curasight's theranostic strategy developing more gentle and targeted diagnosis and treatment of certain types of cancer. The phase 1 trial is part of Curasight's theranostic strategy developing more gentle and targeted diagnosis and treatment of certain types of cancer. "It is a very exciting stage in the development of uTREAT, that we are now ready to enroll patients and progress the development of uTREAT as a potential more targeted therapeutic solution for...
PR Newswire
26/11/2025

Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement…

Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Assignment to New Technology APC 1580 is positive news for Nyxoah’s U.S. commercial rollout by strengthening hospital and ASC economics Mont-Saint-Guibert, Belgium – November 26, 2025, 7:45 am CET / 1:45 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep...
Nasdaq GlobeNewswire
26/11/2025

Galapagos Receives Transparency Notifications from Bank of America

Mechelen, Belgium; November 26, 2025, 07:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian transparency legislation 1, Galapagos received transparency notifications on November 18 and November 19, 2025, from Bank of America Corporation indicating that it positively crossed the threshold of 5% of Galapagos’ voting rights on November 12, 2025 following an acquisition of Galapagos’...
Nasdaq GlobeNewswire
26/11/2025

Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine…

Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo safety concerns observed in any age group by an independent Data Monitoring Committee (DMC)Results confirm benefits of a yearly vaccination prior to each Lyme season Saint-Herblain (France), November 26, 2025– Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive final immunogenicity and safety data from Phase 2 study, VLA15-221,...
Nasdaq GlobeNewswire
26/11/2025

Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare…

Kuros Biosciences to present at the Piper Sandler 37 thAnnual Healthcare Conference Schlieren (Zürich), Switzerland, November 26, 2025– Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, will present at the Piper Sandler 37th Annual Healthcare Conference, taking place December 2–4, 2025 at The Lotte New York Palace in New York City.The Company’s presentation will highlight continued commercial momentum, clinical advancement across the...
Nasdaq GlobeNewswire
26/11/2025

Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5%…

Mitochondrial Myopathies Market Summary Mitochondrial Myopathies Market Summary Discover the new mitochondrial myopathies treatment @ Mitochondrial Myopathies Treatment Market Key Factors Driving the Growth of the Mitochondrial Myopathies Market Improved diagnostics and expanding genetic testing Wider availability of next-generation sequencing, broader use of whole-exome/genome testing and improved clinical awareness are increasing diagnosis rates and enabling patient...
PR Newswire
25/11/2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 47 - 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from November 17th to November 21st 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1117/11/2025FR0010259150 ...
Nasdaq GlobeNewswire
25/11/2025

Oxurion Receives Transparency Notification from Atlas Special Opportunities II…

Leuven, BELGIUM – November 25, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on November 25, 2025, from Atlas Special Opportunities…
Actusnews Wire
25/11/2025

Pediatric Vascular Access Market worth US$833.1 million by 2030 with 7.4% CAGR |…

Browse in-depth TOC on "Pediatric Vascular Access Market" Browse in-depth TOC on "Pediatric Vascular Access Market" 160 - Tables 50 - Figures 300 - Pages By type,the Pediatric Vascular Access market is segmented into catheters, implantable ports, port needles, catheter securement and stabilization, catheter caps & closures, vascular closure devices, IV connectors, syringes and needles, infusion pumps, IV sets & accessories, intraosseous infusion devices, anesthesia...
PR Newswire
25/11/2025

Office Furniture Market Growth Led by Asia Pacific, B2B/Direct Sales Segment…

Asia-Pacific Asia-Pacific Asia-Pacificdominates the office furniture market, driven by expanding office developments, skilled labor availability, and supportive investment inflows. Countries such asIndiaandVietnamare witnessing rapid growth in workspace construction, while sustainability initiatives and the use of eco-friendly materials like recycled panels and low-emission coatings continue to strengthen market momentum. North America North Americaremains a...
PR Newswire
25/11/2025

Dietary Supplements Market to Hit $414.5B by 2033, Growing at 8.9% CAGR - Key…

In addition, the increasing adoption of personalized nutrition, driven by advancements in nutrigenomics and digital health technologies, is reshaping consumer preferences. The market is witnessing demand for targeted supplements that support gut health, cognitive function, stress management, hormonal balance, and overall well-being. Millennials, in particular, show strong interest in supplements with probiotics, nootropics, adaptogens, and herbal extracts. In addition, the increasing adoption...
PR Newswire
25/11/2025

Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics…

MT PLEASANT, S.C., Nov. 25, 2025 /PRNewswire/ -- Innova Therapeutics, a biopharmaceutical company, has announced that it has completed the acquisition of Enci Therapeutics. The acquisition includes Enci Therapeutics' main cancer therapeutic program, IVT-8086. The specific terms of the agreement and financial details regarding the acquisition between Innova Therapeutics and Enci Therapeutics have not been disclosed. MT PLEASANT, S.C. , Nov. 25, 2025 /PRNewswire/ -- Innova Therapeutics, a...
PR Newswire
25/11/2025

Veterinary Reference Laboratory Market worth US$6.46 billion by 2030 with 6.3%…

The veterinary reference laboratory market is witnessing rapid technological advancement driven by innovation in diagnostic methodologies, automation, and molecular testing. Market participants are increasingly focusing on developing advanced diagnostic panels, integrating AI-driven data analysis, and expanding assay menus to enhance accuracy, efficiency, and turnaround time. The adoption of next-generation sequencing (NGS), PCR-based diagnostics, immunodiagnostics, and high-throughput analyzers…
PR Newswire
25/11/2025

VINNO Showcases "Sound, Light, and Air" Integration at MEDICA 2025 -- Global…

VINNO's ULTIMUS platform continues to show how far ultrasound can go. Powered by Ultra-Resolution Microscopy (URM), it captures microvascular details that standard imaging simply cannot see. VINNO's ULTIMUS platform continues to show how far ultrasound can go. Powered by Ultra-Resolution Microscopy (URM), it captures microvascular details that standard imaging simply cannot see. This capability is gaining clinical momentum inEurope, where institutions like University Hospital Erlangen are...
PR Newswire
25/11/2025

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into…

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial evaluating intranasal foralumab in patients with amyotrophic lateral sclerosis (ALS) has been accepted for inclusion in the ALS MyMatch Program at the Sean M. Healey & AMG Center for ALS at Mass General Brigham.The study, supported by a grant from the ALS Association, will be led by Principal Investigators Suma Babu, MBBS, MPH,...
Nasdaq GlobeNewswire
25/11/2025

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar…

Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP ), the European Commission has granted marketing authorizations for Teva’s biosimilars PONLIMSI and DEGEVMA expanding access to important bone health treatments across Europe These approvals mark another significant milestone in Teva’s strong biosimilars portfolio, in line with Teva's Pivot to Growth StrategyThe approvals underscore Teva’s commitment to broadening access to biosimilars...
Nasdaq GlobeNewswire
25/11/2025

Elton John AIDS Foundation and Zipline: $150M US State Department Boost…

Impact Since EJAF's 2023 Support Impact Since EJAF's 2023 Support Kenya&Nigeriaat a glance "From the beginning, the Elton John AIDS Foundation has stood with communities too often left behind, without the healthcare they urgently need and deserve," saidElton John, Founder of the Elton John AIDS Foundation. "Zipline's innovative approach to delivering medical care is exactly the kind of work our Foundation exists to champion. We were their first philanthropic partner in...
PR Newswire
25/11/2025

Avicenna.AI Joins Forces with Ferrum Health to Expand U.S. Access to Advanced…

Ferrum's suite gives clinicians access to advanced AI technologies designed to enhance diagnostic accuracy across oncology, women's and men's health, cardiovascular care, neurology, orthopedics, and more. By adding Avicenna's emergency and high-impact imaging solutions to its expanding library, Ferrum strengthens its position as one of the most comprehensive AI marketplaces in healthcare. Ferrum's suite gives clinicians access to advanced AI technologies designed to enhance diagnostic…
PR Newswire
25/11/2025

Bulat Utemuratov Foundation's autism program wins prestigious AmCham healthcare…

Launched in 2015, the program operates 13 Asyl Miras autism centers in 12 cities across Kazakhstan. It offers free services that combine the expertise of psychologists, speech therapists, and behavioral analysts using internationally recognized evidence-based methods including ABA therapy, JASPER, the Early Childhood Intervention Model, and MCRR crisis management. Over the past decade, more than 17,000 children and their families have received support, while over 300 specialists have been…
PR Newswire
25/11/2025

Amphista Therapeutics announces new AMX-883 data to be presented at the ASH…

AMX-883 shows synergistic efficacy in combination with venetoclax in vivoand prevents the emergence of resistance to venetoclaxin vitro, addressing a major clinical challenge in acute myeloid leukaemia (AML)AMX-883 showed a significant survival benefit and reduced disease burden compared to control treatments, while being well tolerated in a murine pre-clinical experimentData provides compelling evidence of BRD9's critical role in AML and supports progression of AMX-883, as a...
Nasdaq GlobeNewswire
25/11/2025
Altri  Comunicati